{"companies":[{"name":"Aiolos Bio","ticker":"N/A","reason":"A biotech company that focuses on developing therapies for a range of diseases, recently secured significant funding to boost its research efforts."},{"name":"MapLight Therapeutics","ticker":"N/A","reason":"This biotech firm is making waves with its innovative approach in targeted therapies and has garnered substantial investor interest."},{"name":"Agomab Therapeutics","ticker":"N/A","reason":"A pioneering company in regenerative medicine and therapies, Agomab has recently received funding that positions it to advance its groundbreaking research."}]}